Implementation cases, analytical materials, expert publications, and current documents on infection diagnostics, antimicrobial stewardship, and AMR surveillance.
Practical experience from healthcare organizations and regional systems: objectives, implementation architecture, and outcomes.
A unified validation and analytics workflow for healthcare organizations across the region.
A review of the 2025 CMAC publication: the experience of the Yamalo-Nenets Autonomous Okrug in implementing a regional system for automated validation of microbiology reports, continuous AMR surveillance, and real-time analytics.
View implementation
Report quality control and AMR surveillance operate within a single continuous data workflow.
Review of a Poliklinika journal article (2024): how the Botkin Hospital centralized bacteriology lab built an IT-enabled production flow (LIS + services), why export-based surveillance does not scale, and how the next-generation system – ABioGram – adds automated report validation and real-time AMR surveillance.
View implementation
During the pilot, review and discrepancy detection became 150–200 times faster.
Pilot results in the largest laboratory in Moscow (07 Nov–25 Nov 2025): API integration with the laboratory information system, automated interpretation of antimicrobial susceptibility results, 89,117 decision-support messages, and real-time AMR analytics.
View implementation
LIS–ABioGram–HIS integration and analytics based on validated data.
Review of a CMAC (2025) publication: implementation of an integrated digital loop (LIS–ABioGram–HIS), automated antibiogram validation, continuous AMR surveillance, and the impact of expert comments on clinical decision-making.
View implementationReviews of research, methodologies, and data relevant to infection diagnostics, antimicrobial stewardship, and AMR control.
Key results of the 2025 analytical report by the Methodological Verification Center on antimicrobial resistance: pathogen structure among hospitalized patients, resistance levels, carbapenemases, and practical conclusions regarding antimicrobial agents.
A review from CMAC (2025) compares WHO GLASS, CLSI M39, ESCMID, AMRcloud guidance and Russian MR 3.1.0346-24–highlighting key contradictions that matter for local antibiograms, data quality, and stewardship decisions.
How susceptibility testing accuracy, prescribing errors, and AMR diagnostics translate into measurable economic losses–and why even a 10% error rate can cost millions of rubles.
Current Russian and international documents on antimicrobial susceptibility testing, AMR surveillance, and healthcare delivery.
Official document (version 2026-01) on antimicrobial susceptibility testing (AST) for microorganisms.
EUCAST breakpoint tables for interpretation of MICs and zone diameters. Version 16.0, valid from 2026-01-01.
Official documents on healthcare development and antimicrobial resistance surveillance in the Russian Federation.
Official document (version 2025-01) on antimicrobial susceptibility testing (AST) for microorganisms.
EUCAST breakpoint tables for interpretation of MICs and zone diameters. Version 15.0, valid from 2025-01-01.